Prince Akwasi Mensah

Array ( [id] => 3731618 [patent_doc_number] => 05635528 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Intermediates to tetrahydro-beta-carbolines' [patent_app_type] => 1 [patent_app_number] => 8/481716 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29026 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 561 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635528.pdf [firstpage_image] =>[orig_patent_app_number] => 481716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828541 [patent_doc_number] => 05760051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Tetrahydro-beta-carbolines' [patent_app_type] => 1 [patent_app_number] => 8/481714 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27976 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760051.pdf [firstpage_image] =>[orig_patent_app_number] => 481714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648806 [patent_doc_number] => 05639750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Method of inhibiting secretory effects caused by cholera' [patent_app_type] => 1 [patent_app_number] => 8/477313 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 3706 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639750.pdf [firstpage_image] =>[orig_patent_app_number] => 477313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773014 [patent_doc_number] => 05807861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Amine substituted xanthinyl compounds' [patent_app_type] => 1 [patent_app_number] => 8/476911 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14785 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807861.pdf [firstpage_image] =>[orig_patent_app_number] => 476911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3493571 [patent_doc_number] => 05561129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Methods of administering phenothiazines and/or acid addition salts thereof' [patent_app_type] => 1 [patent_app_number] => 8/479113 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6273 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/561/05561129.pdf [firstpage_image] =>[orig_patent_app_number] => 479113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729422 [patent_doc_number] => 05652256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Topical composition for fungal treatment' [patent_app_type] => 1 [patent_app_number] => 8/469380 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2519 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652256.pdf [firstpage_image] =>[orig_patent_app_number] => 469380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3575422 [patent_doc_number] => 05523318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Pyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents' [patent_app_type] => 1 [patent_app_number] => 8/466181 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17602 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523318.pdf [firstpage_image] =>[orig_patent_app_number] => 466181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665521 [patent_doc_number] => 05597816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents' [patent_app_type] => 1 [patent_app_number] => 8/468158 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17593 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597816.pdf [firstpage_image] =>[orig_patent_app_number] => 468158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695421 [patent_doc_number] => 05650443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Method of treatment of parkinson\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/470705 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 980 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650443.pdf [firstpage_image] =>[orig_patent_app_number] => 470705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634834 [patent_doc_number] => 05631270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo [b ]' [patent_app_type] => 1 [patent_app_number] => 8/464994 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6560 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631270.pdf [firstpage_image] =>[orig_patent_app_number] => 464994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724202 [patent_doc_number] => 05672625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Sulfonic stilbene derivatives in the treatment of viral diseases' [patent_app_type] => 1 [patent_app_number] => 8/463582 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 6612 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672625.pdf [firstpage_image] =>[orig_patent_app_number] => 463582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510269 [patent_doc_number] => 05587376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/458949 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5593 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587376.pdf [firstpage_image] =>[orig_patent_app_number] => 458949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848441 [patent_doc_number] => 05719138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Method for complexing a free metal ion' [patent_app_type] => 1 [patent_app_number] => 8/459228 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6464 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719138.pdf [firstpage_image] =>[orig_patent_app_number] => 459228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624443 [patent_doc_number] => 05607964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Clinical marker and therapeutic agent in kidney stone disease and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/458368 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6461 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607964.pdf [firstpage_image] =>[orig_patent_app_number] => 458368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808509 [patent_doc_number] => 05854267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Method for preventing heartburn' [patent_app_type] => 1 [patent_app_number] => 8/459182 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3094 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854267.pdf [firstpage_image] =>[orig_patent_app_number] => 459182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510697 [patent_doc_number] => 05563154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Tetrahydro-quinolinyl/isoquinolinyl-terminal alkylamino ethynyl alanine amino diol compounds for treatment of hypertension' [patent_app_type] => 1 [patent_app_number] => 8/456364 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6932 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563154.pdf [firstpage_image] =>[orig_patent_app_number] => 456364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3493054 [patent_doc_number] => 05536740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-16 [patent_title] => 'Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester' [patent_app_type] => 1 [patent_app_number] => 8/457900 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6112 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/536/05536740.pdf [firstpage_image] =>[orig_patent_app_number] => 457900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562560 [patent_doc_number] => 05525630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Treatment for carbon monoxide poisoning' [patent_app_type] => 1 [patent_app_number] => 8/457580 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1319 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525630.pdf [firstpage_image] =>[orig_patent_app_number] => 457580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3627963 [patent_doc_number] => 05621109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Retroviral protease inhibiting compounds' [patent_app_type] => 1 [patent_app_number] => 8/455922 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45962 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621109.pdf [firstpage_image] =>[orig_patent_app_number] => 455922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612723 [patent_doc_number] => 05565454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions' [patent_app_type] => 1 [patent_app_number] => 8/455354 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3947 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565454.pdf [firstpage_image] =>[orig_patent_app_number] => 455354 [rel_patent_id] =>[rel_patent_doc_number] =>)